Neurosense Therapeutics logo

Neurosense Therapeutics share price today

(NRSN)

Neurosense Therapeutics share price is $1.36 & ₹115.57 as on 21 Dec 2024, 2.30 'hrs' IST

$1.36

0.08

(6.25%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Neurosense Therapeutics share price in Dollar and Rupees. Guide to invest in Neurosense Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Neurosense Therapeutics. Get details on the Indian mutual funds that are investing in Neurosense Therapeutics. Get Analyst recommendations and forecasts along with all the Neurosense Therapeutics's financials.

Neurosense Therapeutics share price movements

  • Today's Low: $1.23
    Today's High: $1.41

    Day's Volatility :12.77%

  • 52 Weeks Low: $0.51
    52 Weeks High: $2.33

    52 Weeks Volatility :78.03%

Neurosense Therapeutics Returns

PeriodNeurosense Therapeutics LtdIndex (Russel 2000)
3 Months
4.99%
0.0%
6 Months
60.89%
0.0%
1 Year
80.13%
0.0%
3 Years
-53.66%
-19.7%

Neurosense Therapeutics Key Statistics

in dollars & INR

Previous Close
$1.28
Open
$1.22
Today's High
$1.41
Today's Low
$1.23
Market Capitalization
$29.6M
Today's Volume
$1.3M
52 Week High
$2.33
52 Week Low
$0.512
Revenue TTM
$0.0
EBITDA
$-11.7M
Earnings Per Share (EPS)
$-0.76
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-494.84%

How to invest in Neurosense Therapeutics from India?

It is very easy for Indian residents to invest directly in Neurosense Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neurosense Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Neurosense Therapeutics or NRSN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neurosense Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neurosense Therapeutics shares which would translate to 0.625 fractional shares of Neurosense Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Neurosense Therapeutics, in just a few clicks!

Returns in Neurosense Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neurosense Therapeutics investment value today

Current value as on today

₹1,81,143

Returns

₹81,143

(+81.14%)

Returns from Neurosense Therapeutics Stock

₹78,947 (+78.95%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Neurosense Therapeutics

-5%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Neurosense Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -5% less investors are searching Neurosense Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Neurosense Therapeutics

  • XTX Topco Ltd

    0.22%

  • Meitav Dash Investments Ltd

    0.19%

  • Citadel Advisors Llc

    0.17%

  • Commonwealth Equity Services Inc

    0.06%

  • Geode Capital Management, LLC

    0.06%

Analyst Recommendation on Neurosense Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Neurosense Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Neurosense Therapeutics

What analysts predicted

Upside of 451.47%

Current:

$1.36

Target:

$7.50

Insights on Neurosense Therapeutics

  • Price Movement

    In the last 7 days, NRSN stock has moved up by 58.1%
  • NRSN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 79.7%

Neurosense Therapeutics Technicals Summary

Sell

Neutral

Buy

Neurosense Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Neurosense Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Neurosense Therapeutics Ltd
51.11%
60.89%
80.13%
-53.66%
-66.34%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Neurosense Therapeutics Ltd
NA
NA
NA
0.0
-4.95
-1.51
NA
-0.11
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Neurosense Therapeutics Ltd
Buy
$29.6M
-66.34%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

About Neurosense Therapeutics

advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa
Organization
Neurosense Therapeutics
Employees
18
CEO
Mr. Alon Ben-Noon
Industry
Miscellaneous

Management People of Neurosense Therapeutics

NameTitle
Mr. Alon Ben-Noon
Co-Founder, CEO & Director
Mr. Or Eisenberg
Chief Financial Officer
Ms. Hagit Binder
Chief Operation Officer
Dr. Niva Russek-Blum Ph.D.
Chief Technology Officer
Dr. Ferenc Tracik M.D.
Chief Medical Officer
Ms. Yael Barak
VP of Quality & Compliance
Ms. Keren Pushett
Head of HR
Mr. Eidan Loushi
C.R.A.

Important FAQs about investing in Neurosense Therapeutics from India :

What is Neurosense Therapeutics share price today?

Neurosense Therapeutics share price today stands at $1.36, Open: $1.22 ; Previous Close: $1.28 ; High: $1.41 ; Low: $1.23 ; 52 Week High: $2.33 ; 52 Week Low: $0.51. The stock opens at $1.22, after a previous close of $1.28. The stock reached a daily high of $1.41 and a low of $1.23, with a 52-week high of $2.33 and a 52-week low of $0.51.

Can Indians buy Neurosense Therapeutics shares?

Yes, Indians can invest in the Neurosense Therapeutics (NRSN) from India.

With INDmoney, you can buy Neurosense Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Neurosense Therapeutics at zero transaction cost.

How can I buy Neurosense Therapeutics shares from India?

It is very easy to buy Neurosense Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neurosense Therapeutics be purchased?

Yes, you can buy fractional shares of Neurosense Therapeutics with INDmoney app.

What are the documents required to start investing in Neurosense Therapeutics stocks?

To start investing in Neurosense Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Neurosense Therapeutics

Today’s highest price of Neurosense Therapeutics (NRSN) is $1.41.

Today’s lowest price of Neurosense Therapeutics (NRSN) is $1.23.

What is today's market capitalisation of Neurosense Therapeutics

Today's market capitalisation of Neurosense Therapeutics NRSN is 29.6M

What is the 52 Week High and Low Range of Neurosense Therapeutics

  • 52 Week High

    $2.33

  • 52 Week Low

    $0.51

What are the historical returns of Neurosense Therapeutics?

  • 1 Month Returns

    51.11%

  • 3 Months Returns

    60.89%

  • 1 Year Returns

    80.13%

  • 5 Years Returns

    -66.34%

Who is the Chief Executive Officer (CEO) of Neurosense Therapeutics

Mr. Alon Ben-Noon is the current Chief Executive Officer (CEO) of Neurosense Therapeutics.